Skip to Content

HPV-associated Cancers


Introductory video transcript:
English / Español

Course Overview

Human papillomavirus (HPV) is a common virus best known as the agent that causes benign warts. However, of the more than 100 types of HPV, about 13 types have been documented as “high risk”; that is they are associated with the development of human cancers.  HPV-related cancers include those of the cervix, vulva, and penis as well as cancers of the rectum, anus, and oropharynx.  Many of these diseases are preventable through HPV vaccination. In this course, a multidisciplinary faculty team discusses HPV biology, the specific cancers that are associated with HPV, the value of and recommendations for HPV vaccination for children, and coverage of conditions diagnosed via the “Breast and Cervical Cancer Early Detection Program”.

Lectures

 

Lois M. Ramondetta, M.D.Introduction to HPV-related Diseases   Top of Page
 
Presenter: Lois M. Ramondetta, M.D.
Professor, Gynecologic Oncology and Reproductive Medicine
 

Summary: Coming soon!

 

Biology of HPV   Top of Page
 
Presenter: Karen Storthz, Ph.D.
Professor Emerita, Diagnostic and Biomedical Sciences
The University of Texas Health Science Center at Houston School of Dentistry
 

Summary: Coming soon!

 
Cervical Cancer   Top of Page
 
Presenter: Andrea Milbourne, M.D.
Professor, Gynecologic Oncology and Reproductive Medicine
 
Presenter: Kathleen Schmeler, M.D.
Associate Professor, Gynecologic Oncology and Reproductive Medicine
 
Presenter: Lois M. Ramondetta, M.D.
Professor, Gynecologic Oncology and Reproductive Medicine

 
Summary: Coming soon!
 

Anal Cancer   Top of Page
 
Presenter: Cathy Eng, M.D.
Associate Professor
Department of Gastrointestinal (GI) Medical Oncology
 

Summary: Coming soon!

 

Kristina R. Dahlstrom, Ph.D.Erich M. Sturgis, M.D., M.P.H.Oropharyngeal Cancer   Top of Page
 
Presenter: Kristina R. Dahlstrom, Ph.D.
Instructor, Head and Neck Surgery
 
Presenter: Erich M. Sturgis, M.D., M.P.H.
Professor, Head and Neck Surgery

 
Summary: “To date more than 150 types of HPV have been described. About 40 of these infect the genital tract and potentially the oral cavity and the oropharynx,” says Kristina R. Dahlstrom, Ph.D., an instructor in the Department of Head and Neck Surgery at The University of Texas MD Anderson Cancer Center. In this lecture, “Oropharyngeal Cancer: Epidemiology,” Dr. Dahlstrom describes the role of HPV in oropharyngeal cancer, risk factors for the disease, why HPV-associated cancers are becoming an epidemic, and trends and incidence in survival. She also talks about methods for prevention of HPV-related oropharyngeal cancer, which includes a newly FDA approved HPV nonavalent vaccine.

When oropharyngeal cancer is HPV-related, there typically are no symptoms, but there may be a lump in the neck. In his lecture, “Oropharyngeal Cancer: Clinical Implications of the HPV Epidemic,” Erich M. Sturgis, M.D., Professor of Head and Neck Surgery and Epidemiology, describes the pathophysiology of HPV infection and malignant transformation, as well as the clinical differences between HPV-positive cancers and HPV-negative cancers. He also discusses current clinical trials.

 

Penile Cancer   Top of Page
 
Presenter: Curtis A. Pettaway, M.D.
Professor
Department of Urology
 

Summary: Coming soon!

 

Kathleen Schmeler, M.D.
HPV Vaccination   Top of Page
 
Presenter: Kathleen Schmeler, M.D.
Associate Professor, Gynecologic Oncology and Reproductive Medicine
 

Summary: In the United States, an estimated 14 million persons are newly infected annually with genital human papillomavirus (HPV), making this infection the nation’s most common sexually transmitted infection. In 2009, nearly 35,000 HPV-attributable cancers were reported in the United States. Of these, 39% occurred in males. The CDC Advisory Committee on Immunization Practices currently recommends routine HPV vaccination for all persons aged 11–12 years.  In her lecture, “Human Papillomavirus (HPV) Vaccination,” Kathleen Schmeler, MD, Associate Professor in the Department of Gynecologic Oncology and Reproductive Medicine, explains the epidemiology of cervical cancer and how to screen for and treat cervical cancer. Specific vaccine recommendations and the role of HPV vaccination in preventing cervical cancer are presented.

 

Medicaid for Breast and Cervical Cancer   Top of Page
 
Presenter: Maria E. Daheri, RN
Cervical Nurse Case Manager
Harris Health System
 

Summary: Coming soon!

 

 

For further information or assistance, to provide feedback on this web site, or to request a specific professional oncology education topic, please e-mail Professional Oncology Education.

Course Options and Resources


© 2015 The University of Texas MD Anderson Cancer Center